Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: A pilot study

Journal of Veterinary Cardiology

Volumn 11, Issue SUPPL. 1, 2009, Pages

  Schmidt, M K ^a   Reynolds, C A ^b   Estrada, A H ^a   Prosek R ^a   Maisenbacher, H W ^a   Sleeper, M M ^b   Oyama, M A ^b  

^a University of Florida   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain natriuretic peptide; Cardiac disease; Natriuretic peptides; Renal disease

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; NITROGEN; UREA;

ARTICLE; BLOOD CHEMISTRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOG; ECHOCARDIOGRAPHY; FALSE POSITIVE RESULT; FEMALE; HEART FUNCTION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MALE; MEDICAL RESEARCH; NONHUMAN; PHYSICAL EXAMINATION; PILOT STUDY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; UREMIA; URINALYSIS;

ANIMALS; AZOTEMIA; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CASE-CONTROL STUDIES; CREATININE; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; FEMALE; HEART; KIDNEY DISEASES; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PILOT PROJECTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

ANIMALIA; CANIS FAMILIARIS;

EID: 67349172945     PISSN: 17602734     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvc.2009.02.001     Document Type: Article

References (21)

1. Sisson D.D. Neuroendocrine evaluation of cardiac disease. Vet Clin North Am Small Anim Pract 34 (2004) 1105-1126
2. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., Omland T., Storrow A.B., Abraham W.T., Wu A.H.B., Clopton P., Steg P.G., Westheim A., Knudsen C.W., Perez A., Kazanegra R., Herrman H.C., McCullough P.A., and for the Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
3. McCullough P.A., and Sandberg K.R. Sorting out the evidence on natriuretic peptides. Rev Cardiovasc Med 4 Suppl. 4 (2003) S13-S19
4. Prošek R., Sisson D.D., Oyama M.A., and Solter P.F. Distinguishing cardiac and non-cardiac dyspnea in 48 dogs via plasma atrial natriuretic factor, B-type natriuretic factor, endothelin, and cardiac troponin-I. J Vet Intern Med 21 (2007) 238-242
5. Oyama M.A., Fox P.R., Rush J.E., Rozanski E.A., and Lesser M. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity. J Am Vet Med Assoc 232 10 (2008) 1496-1503
6. Boswood A., Dukes-McEwan J., Loureiro J., James R.A., Martin M., Stafford-Johnson M., Smith P., Little C., and Attree S. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease. J Small Anim Pract 49 (2008) 26-32
7. Johnston N., Jernberg T., Lindahl B., Lindback J., Stridsberg M., Larsson A., Venge P., and Wallentin L. Biochemical indicators of cardiac and renal function in a healthy elderly population. Clin Biochem 37 (2004) 210-216
8. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett J.C. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 (2002) 976-982
9. Felker G.M., Petersen J.W., and Mark D.B. Natriuretic peptides in the diagnosis and management of heart failure. Can Med Assoc J 175 (2006) 611-617
10. Richards M., Nicholls M.G., Espiner E.A., Lainchbury J.G., Troughton R.W., Elliott J., Frampton C.M., Crozier I.G., Yandle T.G., Doughty R., MacMahon S., Sharpe N., and for the Christchurch Cardioendocrine Research Group and the Australia-New Zealand Heart Failure Group. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. Chronic coronary artery disease. J Am Coll Cardiol 47 1 (2006) 52-60
11. Luchner A., Hengstenberg C., Lowel H., Riegger G.A.J., Schunkert H., and Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46 (2005) 118-123
12. Anwaruddin S., Lloyd-Jones D.M., Baggish A., Chen A., Krauser D., Tung R., Chae C., and Januzzi J.L. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement. Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Am Coll Cardiol 47 1 (2006) 91-97
13. McCullough P.A., Kuncheria J., and Mathur V.S. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. Rev Cardiovasc Med 4 Suppl. 7 (2003) S3-S12
14. McCullough P.A., Duc P., Omland T., McCord J., Nowak R.M., Hollander J.E., Herrmann H.C., Steg P.G., Westheim A., Knudsen C.W., Storrow A.B., Clopton P., Krishnaswamy P., Kazanegra R., Maisel A.S., and for the Breathing Not Properly Multinational Study Investigators. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 41 (2003) 571-579
15. deFillippi C.R., Seliger S.L., Maynard S., and Christenson R.H. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin Chem 53 8 (2007) 1511-1519
16. McCullough P.A., and Sandberg K.R. B-type natriuretic peptide and renal disease. Heart Fail Rev 8 (2003) 355-358
17. van Kimmenade R.R., Januzzi J.L., Baggish A., Lainchbury J.G., Bayes-Genis A., Richards A.M., and Pinto Y.M. Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure. J Am Coll Cardiol 48 8 (2006) 1621-1627
18. Bruch A., Reinecke H., Stypmann J., Rothenburger M., Schmid C., Breithardt G., Wichter T., and Graduas R. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure. J Heart Lung Transplant 25 9 (2006) 1135-1141
19. DeFilippi C., can Kimmenade R.R., and Pinto Y.M. Amino-terminal pro-B-type natriuretic peptide testing in renal disease. Am J Cardiol 101 Suppl. (2008) 82A-88A
20. Schou M., Dalsgaard M.K., Clemmesen O., Dawson E.A., Yoshiga C.C., Nielsen H.B., Gustafsson F., Hildebrandt P.R., and Secher N.H. Kidneys extract BNP and NT-proBNP in healthy young men. J Appl Physiol 99 (2005) 1676-1680
21. Austin W.J., Bhalla V., Hernandez-Arce I., Isakson S.R., Beede J., Clopton P., Maisel A.S., and Fitzgerald R.L. Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease. Am J Clin Pathol 126 (2006) 506-512